Contrast agent BR
Showing 1 - 25 of >10,000
Renal Disease Trial in Seoul (Contrast enhanced Kidney CT)
Recruiting
- Renal Disease
- Contrast enhanced Kidney CT
-
Seoul, Jong-no Gu, Korea, Republic ofSeoul National University Hospital
Apr 16, 2023
Small Bowel Adhesion, Small Bowel Obstruction Trial (Low osmolar contrast, Sterile water)
Not yet recruiting
- Small Bowel Adhesion
- Small Bowel Obstruction
- Low osmolar contrast
- Sterile water
- (no location specified)
Nov 14, 2023
Myocardial Fibrosis Trial in Baltimore (Elucirem (Gadopiclenol))
Not yet recruiting
- Myocardial Fibrosis
- Elucirem (Gadopiclenol)
-
Baltimore, MarylandJohns Hopkins School of Medicine
Jul 13, 2023
Gadolinium-based Contrast Agent Reduction in Brain MRI (MAGNET)
Recruiting
- Brain Diseases
- Low-dose GBCA levels
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Mar 2, 2023
Breast Tumor, Contrast-enhanced Spectral Mammography Trial in Maastricht (CESM with a reduced dose of contrast agent)
Terminated
- Breast Neoplasm
- Contrast-enhanced Spectral Mammography
- CESM with a reduced dose of contrast agent
-
Maastricht, NetherlandsMaastricht University Medical Center
Sep 8, 2022
Unspecified Disorder of Stomach and Duodenum Trial in Jinan (KANG XIAN, TIAN XIA)
Completed
- Unspecified Disorder of Stomach and Duodenum
- KANG XIAN
- TIAN XIA
-
Jinan, Shandong, ChinaQilu Hospital Of Shangdong University
Jan 6, 2023
Pediatric Congenital Heart Disease Trial in Los Angeles (ferumoxytol, gadofosveset)
Completed
- Pediatric Congenital Heart Disease
-
Los Angeles, CaliforniaUCLA Medical Center
Nov 22, 2022
Transcatheter Aortic Valve Replacement Trial in Baltimore (Iodinated Contrast Agent (Omnipaque), Dual Energy CT)
Not yet recruiting
- Transcatheter Aortic Valve Replacement
- Iodinated Contrast Agent (Omnipaque)
- Dual Energy CT
-
Baltimore, MarylandUniversity of Maryland Medical Center
Feb 24, 2023
Advanced Solid Tumor Trial in Hangzhou (BR101)
Recruiting
- Advanced Solid Tumor
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University Medical Co
Aug 14, 2023
Breast Carcinoma Trial in Houston (procedure, drug, other)
Recruiting
- Breast Carcinoma
- Contrast Enhanced Digital Mammography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2022
Hepatocellular Carcinoma Trial in Seoul (radiation, drug, other)
Completed
- Hepatocellular Carcinoma
- Low radiation dose CT
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 29, 2022
MRI-based 3D Hip Labrum and Cartilage Morphology in Hip
Recruiting
- Hip Disease
- Non- contrast Magnetic Resonance Imaging (MRI) of the hip
- Magnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agent
-
Bern, SwitzerlandUniversity Hospital of Bern (Inselspital)
Oct 17, 2023
Healthy Trial in Lund (Lumentin® 44 Powder for oral foam)
Completed
- Healthy
- Lumentin® 44 Powder for oral foam
-
Lund, Skåne, SwedenPeritusClinic
Mar 10, 2023
Mammographic Microcalcifications
Recruiting
- Breast Carcinoma
- Biospecimen Collection
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Breast Carcinoma, Invasive Breast Carcinoma Trial in Houston (procedure, other, drug)
Active, not recruiting
- Breast Carcinoma
- Invasive Breast Carcinoma
- Contrast-Enhanced Mammography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Breast Cancer Diagnosis Trial in Erlangen, Groningen, Leiden (Injection of contrast enhancing agent Gadovist for MRI
Not yet recruiting
- Breast Cancer Diagnosis
- Injection of contrast enhancing agent Gadovist for MRI investigation
- Injection of contrast enhancing agent Imeron for B-CT investigation
-
Erlangen, Germany
- +2 more
Aug 2, 2023
Called GUS to Understand How Much of Contrast Agent Gadavist is
Not yet recruiting
- Contrast Enhancement in Magnetic Resonance Imaging
- Gadobutrol (Gadavist/Gadovist, BAY86-4875)
-
Pittsburgh, Pennsylvania
- +1 more
Aug 12, 2022
Cholangitis Trial in Lanzhou, Xi'an, Tianjin (Injection of 37? contrast agent)
Recruiting
- Cholangitis
- Injection of 37℃ contrast agent
-
Lanzhou, Gansu, China
- +2 more
Nov 18, 2021
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
Recruiting
- Crohn Disease
- Ultrasound Microbubble Contrast Agent
- Ultrasound Imaging
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 22, 2022
GI Carcinoma, GI Disorders Trial in Rochester, Seattle (NX9 Oral Contrast Agent)
Completed
- GI Carcinoma
- GI Disorders
- NX9 Oral Contrast Agent
-
Rochester, Minnesota
- +1 more
Jan 13, 2022